Paper42897352PubMed
NUAK isoforms promote glucose and glutamine metabolic reprogramming driven colon cancer progression and migration through regulation of AMPK/mTOR signaling.
Raj ASWW and 4 others. J Mol Med (Berl), 2026.
Cite this record
ConductScience Library. NUAK isoforms promote glucose and glutamine metabolic reprogramming driven colon cancer progression and migration through regulation of AMPK/mTOR signaling. Papers, record 42897352. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42897352
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- NUAK isoforms promote glucose and glutamine metabolic reprogramming driven colon cancer progression and migration through regulation of AMPK/mTOR signaling.
- Journal
- J Mol Med (Berl)
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-11-05
Source PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| TOR Serine-Threonine Kinases | Major topic |
| Glucose | Major topic |
| Glutamine | Major topic |
| Signal Transduction | Major topic |
| AMP-Activated Protein Kinases | Major topic |
| Protein Kinases | Major topic |
| Repressor Proteins | Major topic |
| Colonic Neoplasms | Major topic |
| Humans | |
| Metabolic Reprogramming | |
| Cell Movement | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Disease Progression | |
| Animals | |
| Protein Serine-Threonine Kinases |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| EMDR/IRP/IG/15/2023-0000072 | Indian Council of Medical Research | PubMed | ||
| KIIC/Incubatee/DST Ignition Grant/004/05/03/2024 | KIIC/DST Ignition Grant | PubMed |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23274086 | AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. | Cell Metab | 2013 | https://conductscience.org/library/papers/23274086 | PubMed |
| 2 | 25037503 | The pentose phosphate pathway and cancer. | Trends Biochem Sci | 2014 | https://conductscience.org/library/papers/25037503 | PubMed |
| 3 | 36875093 | The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment. | Front Immunol | 2023 | https://conductscience.org/library/papers/36875093 | PubMed |
| 4 | 37852707 | Colorectal cancer: A health and economic problem. | Best Pract Res Clin Gastroenterol | 2023 | https://conductscience.org/library/papers/37852707 | PubMed |
| 5 | 38925848 | NUAK2 Inhibitors, KHKI-01128 and KHKI-01215, Exhibit Potent Anticancer Activity Against SW480 Colorectal Cancer Cells. | Anticancer Res | 2024 | https://conductscience.org/library/papers/38925848 | PubMed |
| 6 | 35192892 | MARK2/4 promotes Warburg effect and cell growth in non-small cell lung carcinoma through the AMPKα1/mTOR/HIF-1α signaling pathway. | Biochim Biophys Acta Mol Cell Res | 2022 | https://conductscience.org/library/papers/35192892 | PubMed |
| 7 | 31817676 | Targeting mTOR and Metabolism in Cancer: Lessons and Innovations. | Cells | 2019 | https://conductscience.org/library/papers/31817676 | PubMed |
| 8 | 29500295 | Colorectal Tumors Require NUAK1 for Protection from Oxidative Stress. | Cancer Discov | 2018 | https://conductscience.org/library/papers/29500295 | PubMed |
| 9 | 33367927 | Critical role of mTOR in regulating aerobic glycolysis in carcinogenesis (Review). | Int J Oncol | 2021 | https://conductscience.org/library/papers/33367927 | PubMed |
| 10 | 39294640 | Altered metabolism in cancer: insights into energy pathways and therapeutic targets. | Mol Cancer | 2024 | https://conductscience.org/library/papers/39294640 | PubMed |
| 11 | 37009798 | Targeting glutamine metabolism as a therapeutic strategy for cancer. | Exp Mol Med | 2023 | https://conductscience.org/library/papers/37009798 | PubMed |
| 12 | 36978930 | Glutamine Starvation Affects Cell Cycle, Oxidative Homeostasis and Metabolism in Colorectal Cancer Cells. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/36978930 | PubMed |
| 13 | 24838344 | Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice. | Mol Carcinog | 2015 | https://conductscience.org/library/papers/24838344 | PubMed |
| 14 | 33545220 | Distinctive role of SIK1 and SIK3 isoforms in aerobic glycolysis and cell growth of breast cancer through the regulation of p53 and mTOR signaling pathways. | Biochim Biophys Acta Mol Cell Res | 2021 | https://conductscience.org/library/papers/33545220 | PubMed |
| 15 | 34243011 | Global colorectal cancer burden in 2020 and projections to 2040. | Transl Oncol | 2021 | https://conductscience.org/library/papers/34243011 | PubMed |
| 16 | 26778478 | The Warburg Effect: How Does it Benefit Cancer Cells? | Trends Biochem Sci | 2016 | https://conductscience.org/library/papers/26778478 | PubMed |
| 17 | 39965261 | NUAKs facilitate mTOR-mediated NSCLC proliferation and metastasis by modulating glucose metabolism and inhibiting p53 activity. | Biochim Biophys Acta Mol Cell Res | 2025 | https://conductscience.org/library/papers/39965261 | PubMed |
| 18 | 40025169 | Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications. | Exp Mol Med | 2025 | https://conductscience.org/library/papers/40025169 | PubMed |
| 19 | 29212303 | Targeting Glutamine Metabolism for Cancer Treatment. | Biomol Ther (Seoul) | 2018 | https://conductscience.org/library/papers/29212303 | PubMed |
| 20 | 40598593 | Targeting glutamine metabolism as a potential target for cancer treatment. | J Exp Clin Cancer Res | 2025 | https://conductscience.org/library/papers/40598593 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42897352
GET https://conductscience.org/api/papers/v1/42897352/references?page=2